BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12680188)

  • 1. Src tyrosine kinase but not activated Ras augments sensitivity to taxanes through apoptosis in human adenocarcinoma cells.
    Boudny V; Nakano S
    Anticancer Res; 2003; 23(1A):7-12. PubMed ID: 12680188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Src tyrosine kinase augments taxotere-induced apoptosis through enhanced expression and phosphorylation of Bcl-2.
    Boudny V; Nakano S
    Br J Cancer; 2002 Feb; 86(3):463-9. PubMed ID: 11875716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated Src and Ras induce gefitinib resistance by activation of signaling pathways downstream of epidermal growth factor receptor in human gallbladder adenocarcinoma cells.
    Qin B; Ariyama H; Baba E; Tanaka R; Kusaba H; Harada M; Nakano S
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):577-84. PubMed ID: 16532343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. v-src induces cisplatin resistance by increasing the repair of cisplatin-DNA interstrand cross-links in human gallbladder adenocarcinoma cells.
    Masumoto N; Nakano S; Fujishima H; Kohno K; Niho Y
    Int J Cancer; 1999 Mar; 80(5):731-7. PubMed ID: 10048975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct tumorigenic conversion of human gallbladder carcinoma cells by v-src but not by activated c-H-ras oncogene.
    Tatsumoto T; Nakano S; Shimizu K; Ono M; Esaki T; Ohshima K; Niho Y
    Int J Cancer; 1995 Apr; 61(2):206-13. PubMed ID: 7705949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of malignant growth potentials of v-Src-transformed human gallbladder epithelial cells by adenovirus-mediated dominant negative H-Ras.
    Tokumitsu Y; Nakano S; Ueno H; Niho Y
    J Cell Physiol; 2000 May; 183(2):221-7. PubMed ID: 10737897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased protein kinase C alpha expression in human colonic Caco-2 cells after insertion of human Ha-ras or polyoma virus middle T oncogenes.
    Delage S; Chastre E; Empereur S; Wicek D; VeissiƩre D; Capeau J; Gespach C; Cherqui G
    Cancer Res; 1993 Jun; 53(12):2762-70. PubMed ID: 8504416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential anti-tumor activities of curcumin against Ras- and Src-activated human adenocarcinoma cells.
    Ono M; Higuchi T; Takeshima M; Chen C; Nakano S
    Biochem Biophys Res Commun; 2013 Jun; 436(2):186-91. PubMed ID: 23726918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of chemotherapeutic agents induced-apoptosis associated with activation of c-Jun N-terminal kinase 1 and caspase 3 (CPP32) in bax-transfected gastric cancer cells.
    Kim R; Ohi Y; Inoue H; Toge T
    Anticancer Res; 2000; 20(1A):439-44. PubMed ID: 10769693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of Taxol-induced cell death are concentration dependent.
    Torres K; Horwitz SB
    Cancer Res; 1998 Aug; 58(16):3620-6. PubMed ID: 9721870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cell signaling and CDDP resistance].
    Masumoto N; Nakano S
    Gan To Kagaku Ryoho; 1997 Feb; 24(4):424-30. PubMed ID: 9063479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. v-Src suppresses SHPS-1 expression via the Ras-MAP kinase pathway to promote the oncogenic growth of cells.
    Machida K; Matsuda S; Yamaki K; Senga T; Thant AA; Kurata H; Miyazaki K; Hayashi K; Okuda T; Kitamura T; Hayakawa T; Hamaguchi M
    Oncogene; 2000 Mar; 19(13):1710-8. PubMed ID: 10763828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of anoikis by v-Src but not by activated c-H-ras in human gallbladder epithelial cells.
    Hisano C; Tanaka R; Fujishima H; Ariyama H; Tsuchiya T; Tatsumoto T; Mitsugi K; Nakamura M; Nakano S
    Cell Biol Int; 2003; 27(5):415-21. PubMed ID: 12758089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AKT2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells.
    Liu AX; Testa JR; Hamilton TC; Jove R; Nicosia SV; Cheng JQ
    Cancer Res; 1998 Jul; 58(14):2973-7. PubMed ID: 9679957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive activation of Jak-2 and Tyk-2 in a v-Src-transformed human gallbladder adenocarcinoma cell line.
    Murakami Y; Nakano S; Niho Y; Hamasaki N; Izuhara K
    J Cell Physiol; 1998 May; 175(2):220-8. PubMed ID: 9525481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes.
    Amundadottir LT; Leder P
    Oncogene; 1998 Feb; 16(6):737-46. PubMed ID: 9488037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taxanes propagate apoptosis via two cell populations with distinctive cytological and molecular traits.
    Moos PJ; Fitzpatrick FA
    Cell Growth Differ; 1998 Aug; 9(8):687-97. PubMed ID: 9716185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant RAS selectively promotes sensitivity of myeloid leukemia cells to apoptosis by a protein kinase C-dependent process.
    Gallagher AP; Burnett AK; Bowen DT; Darley RL
    Cancer Res; 1998 May; 58(9):2029-35. PubMed ID: 9581849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of activated c-erbB-2 oncogene induces sensitivity to cisplatin in human gallbladder adenocarcinoma cells.
    Boudny V; Murakami Y; Nakano S; Niho Y
    Anticancer Res; 1999; 19(6B):5203-6. PubMed ID: 10697535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taxotere activates transcription factor AP-1 in association with apoptotic cell death in gastric cancer cell lines.
    Kim R; Ohi Y; Inoue H; Toge T
    Anticancer Res; 1999; 19(6B):5399-405. PubMed ID: 10697568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.